News

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has ...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...
L-Leucine (amount not specified): An essential amino acid, L-leucine helps preserve lean muscle mass during weight loss, ...
MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY ...
CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London ...
Spectral Medical Inc. (“ Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a ...
The Dermatology Group of Arkansas are thrilled to welcome their newest, double board-certified specialist, Dr. Jessica Pillow, who joins the Little Rock, skin care-focused practice this summer. Dr.
SANTA YNEZ, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Raw Garden, California’s leading Clean Green-certified cannabis ...
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence ...
Located in La Rochelle, on the premises of a long-standing Spineway partner, the new line includes a clean room for injection operations. In line with the schedule 1, the first LP-ESP prostheses went ...
Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced ...
IRB approval from TASMC follows Clearmind’s prior regulatory milestones, including U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug (IND) application and IRB approvals ...